It has recently been demonstrated that its performance characteristics for diagnosing advanced fibrosis in NAFLD cases are better than those of other similar panels (such as NAFLD fibrosis score, AST:ALT ratio, AST:platelet ratio index, etc.)that do not require additional testing [16]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.